Trial Profile
A prospective, cohort study, Efficacy and safety of bevacizumab in patients with non-squamous non-small cell lung cancer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 11 Dec 2015 New trial record